• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Will Cannabis Genetics Be Restricted?

A redefinition of hemp under federal law, set to take effect Nov. 12, spells the end of Farm Bill safeguards for numerous hemp-derived THC products across the country: low-dose beverages as well as THCA flower and delta-8 THC edibles, vapes and other products available at gas stops and smoke shops.

But the hemp prohibition also creates a significant complication for the legal cannabis industry. Seeds from cannabis varieties that produce flower with more than 0.3% THC are no longer legal to ship out of state.

Although seed purchases will likely continue in authorized states, the changes threaten to close some seed suppliers and genetics businesses, observers say, while causing supply-chain problems for cannabis growers and retailers.

"If this language goes through, we will need pop-up stores to offer seeds in each state where it's permitted," Campanella said. "Which is why we're also providing clones and tissue culture, because that's not covered in the bill."

When are cannabis genetics and clones illegal to ship across state lines?

The updated regulations classify seeds depending on the THC capacity of the mother plant. Genetic material such as seeds and clones are made illegal if the final product crosses the threshold.

For now, seeds are still shipping under the 2018 Farm Bill's status quo. But the time is ticking for businesses like Brothers Grimm and for cannabis cultivators who fear supply chain disruptions if out-of-state availability to genetics is banned.

Most of the cannabis industry remains mostly unaware of the impending shutdown of the interstate genetics market, said Ryan Power, cofounder of Sebastopol, California-based company Atlas Seed.

Without federal intervention in the way of a carve-out for seeds or a general moratorium, many seed providers will simply be shuttered come November, he added.

"We are operating legally now, but if that shifts, it will upend the legal licensed industry in every state," said Power, whose clientele includes seed suppliers as well as licensed business cultivators.

"Customers are going to lose choice, and it will be a significant shutdown for many people."

What are cannabis seed suppliers doing to remain legal after the government hemp ban?

Sagui Silber has previously recalibrated Silberhaze Genetics, his Ohio genetics company, because of state Senate Bill 56, which tightened cannabis oversight in that state while also limiting hemp-derived THC items to licensed cannabis retailers.

Previously a seed supplier, Silberhaze is now focused on the branding, preservation and IP safeguarding of elite plant genetics.

That's because seed businesses hoping to remain compliant in this new environment must have airtight documentation, he said.

"You have to prove where this stuff comes from, so it's extremely important to have documentation, even to the extent where you have breeder names," Silber said.

"Smaller businesses will have to operate with improved records and a better chain of possession," he added. "We want that documentation ourselves, because we don't want to be dealing with questionable sources."

To avoid seizures and other legal fallout, seed business owners must "get their affairs in order" before the new regulations take effect, Silber said.

"Review all your materials immediately, and categorize what you can," Silber said. "Take inventory, document your heritage, preserve cultivator records, and arrange any cannabinoid or terpene data you currently have. If regulations shift, you'll be in a much better position to comprehend what may be affected and make educated decisions."

Does government marijuana rescheduling impact cannabis genetics?

Silber believes U.S. Drug Enforcement Administration registration may be necessary for businesses engaged in research.

But for the time being, seed companies can't enroll with the DEA like state-licensed medical cannabis businesses can. Such a pathway is unavailable to seed banks, https://nativesusa.com/) nurseries or genetics companies, said Jim Ickes, a lawyer and partner with Frantz Ward's cannabis law group in Cleveland.

"Genetics activity may be happening inside larger state-licensed therapeutic marijuana businesses, as some states permit dispensaries or registered medical operators to offer seeds, clones or personal growing materials," he said.

"But that is distinct from the DEA creating a freestanding seed supplier registration category."

Some genetics companies are currently changing operational practices to comply with the new law. According to Ickes, they must answer questions including:

• Which of our lines produce plants over 0.3% total THC?
• Which seeds survive as hemp after Nov. 12, 2026, and which don't?
• What does our catalog look like once we sort it against the genetics exclusion?

Ickes also recognizes confusion from clients who believed federal rescheduling of therapeutic marijuana would resolve their situation with financial institutions. However, the latest regulatory language has shifted those conversations beyond the fundamentals of classification, he said.

"Banks ask whether this particular revenue source is legal, whether it ties to state-licensed operations, or whether there's interstate-commerce risk," said Ickes.

"After November, a seed bank selling drug-type genetics can't address the initial question with the hemp classification. It has to refer to a lawful state cannabis pathway instead. Seed banks dealing in genuine industrial-hemp seed keep the cleaner story."

What's the future of cannabis genetics?

Campanella is part of a emerging coalition of other breeders, farmers and researchers that's arguing seeds are better defined as agricultural inputs than controlled substances. To that end, seeds should be overseen by the U.S. Department of Agriculture, leaving the DEA to focus its enforcement efforts elsewhere.

"How do you control something based on what it might become one day?" said Campanella. "Our choice is to have that language removed, or get seeds regulated by the USDA as a hemp product."

But in the meantime, Campanella is restructuring Brothers Grimm to function outside the reach of changing federal oversight. The business plans to keep its Colorado seed facility while positioning its Oklahoma tissue cultivation facility as a safeguard against federal prohibition of cannabis seeds.

As she explained: "If things evolve in a way where we can't focus on interstate shipping, we'll have other resources to meet people's requirements without getting ourselves in trouble."